Skycar Developer, Moller International, Sets Date for 2013

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Skycar Developer, Moller International, Sets Date for 2013 Annual Shareholders' Meeting

Davis, CA, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Moller International, Inc. (MI) (OTC-QB: MLER), the developer of the Skycar® aircraft, the Rotapower® line of rotary engines and the Aerobot® line of Unmanned Aerial Vehicles (UAV) will conduct its 2013 Annual Shareholders meeting on Saturday, November 16, 2013 from 10:00 AM to noon.

The meeting will be held at 1632 Da Vinci Ct., Davis, CA 95618-4860, which is adjacent to MI's main offices. You can park at 1632 Da Vinci Ct. or at MI's offices at 1222 Research Park Dr.

The purpose of the meeting is:

1.    Election of Board of Directors

2.    Annual report to shareholders

3.    Such other business as may be properly brought up at the meeting

Shareholders of record on the books of the corporation at the close of business on November 15, 2013 will be entitled to vote at the meeting. All shareholders are cordially invited to attend the meeting in person. It is important that your shares be represented regardless of the number you own. Please contact the company and request a proxy ballot if you are unable to attend in person.

Freedom Motors Annual Shareholders' meeting will be held simultaneously with the MI session. Matters specifically oriented to Freedom Motors shareholders will be addressed.

Following the meetings, Moller International's Skycar® 400 and other products will be on display at the corporate offices.

About Moller International

Moller International (OTC-QB: MLER) formerly Moller Aircraft had its origins in research carried out by Dr. Paul Moller when he tested a scale model of his VTOL capable aircraft in 1961.  A full-size version of the earlier VTOL aircraft was demonstrated in 1965. In 1967, research was conducted with the specific purpose of developing vertical takeoff aircraft for the consumer market.

Today, Moller International is a fully reporting public company that has continued to develop a number of VTOL aircraft employing Rotapower® engines and stabilization systems used not only in creating the Skycar® 400 and the Neuera, but also other VTOL aircraft targeted at the military, public safety, commercial and consumer markets.

The Skycar® has been featured on a number of TV programs including CBS 60 Minutes, "Highway In the Sky", NBC's Today Show "Today's American Story", and History Channel's, "Greatest Movie Gadgets: Then and Now."

About Freedom Motors

Freedom Motors was founded in 1997 as a wholly owned division of Moller International.  In 2001 it became a separate corporation that was exclusively licensed to manufacture, sub-license and sell Rotapower® engines throughout the world.  It later demonstrated that its Rotapower® engine could meet California's requirements for ULEV while running on gasoline and the Super Ultra Low Emissions Vehicle (SULEV) levels on ethanol.

The company recently developed and is patenting a compound version of its Rotapower engine that has the potential to achieve extremely low fuel consumption as well.  The new engine is particularly well suited to be used as the backup power source for a Plug-in Hybrid Electric Vehicle (PHEV).

Safe Harbor Statement

Except for historic information contained in this release, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, the company's ability to attract qualified management, raise sufficient capital to execute its business plan, and effectively compete against similar companies.

Bruce Calkins Moller International 1222 Research Park Drive Davis, CA 95618-4849 (530) 756-5086

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 23

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 32

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kotak Mahindra Bank's Innovative Tech Strategies

Updated Category News Views 587

Kotak Mahindra Bank's Commitment to Digital Transformation Kotak Mahindra Bank is at the forefront of revolutionizing financial services through its innovative technology strategies. Their latest report dives deep into the bank's extensive tech activities, highlighting how it leverages digital transformation to enhance customer experience and streamline operations....

Continue Reading
Star Group, L.P. Reflects on Fiscal 2024 Performance Updates

Updated Category News Views 349

Star Group's Fiscal 2024 Insights and Performance Analysis As the fiscal year wraps up, Star Group, L.P. (NYSE: SGU), a respected home energy distributor, shares its financial performance that ended on September 30, 2024. Amidst the prevailing challenges in the energy market, the company continues its commitment to delivering quality services while adapting to market...

Continue Reading
Krystal Biotech Launches Clinical Trial for Eye Therapy KB801

Updated Category News Views 148

Krystal Biotech Begins Phase 1/2 Trial of KB801 Krystal Biotech, Inc. (NASDAQ: KRYS) has recently announced exciting developments in its ophthalmology pipeline with the initiation of a Phase 1/2 clinical trial for KB801, aimed at treating neurotrophic keratitis (NK). This 2:1 randomized, double-masked, multicenter, placebo-controlled study, named EMERALD-1, marks a...

Continue Reading
Key Updates on the Annual General Meeting of Ignitis Group

Updated Category News Views 163

Exciting Updates for the Ignitis Group Shareholders The retained earnings figure for AB “Ignitis grup?” has been amended for the upcoming Annual General Meeting. It now stands at EUR 320,319,368.41, following a revision made only to the English version of the document. This adjustment reflects the company’s commitment to transparency and accuracy in their financial...

Continue Reading
Transforming Connectivity: The Future of mmWave Sensors Growth

Updated Category News Views 104

The mmWave sensors market was set on a blistering growth path back in 2023, valued at around USD 0.25 billion. By the time you fast-forward to 2032, projections had it skyrocketing to USD 2.40 billion, boasting a staggering CAGR of 28.59% from 2024 through 2032. You'd think this kind of momentum would have traders buzzing—oh wait, they were, especially as the push for...

Continue Reading